US Patent 7060720 Inhibitors of IMPDH enzyme
Patent 7060720 was granted and assigned to Bristol-Myers Squibb on June, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 19 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Nov, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Article (+322 characters)
Article
Patent abstract
The present invention discloses the identification of the novel inhibitors of IMPDH (inosine-5′-monophosphate dehydrogenase). The compounds and pharmaceutical compositions disclosed herein are useful in treating or preventing IMPDH associated disorders, such as transplant rejection and autoimmune diseases.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Edwin J. Iwanowicz0
Henry H. Gu0
T. G. Murali Dhar0
Date of Patent
June 13, 2006
0Patent Application Number
107172870
Date Filed
November 19, 2003
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 7060720 Inhibitors of IMPDH enzyme
Find more entities like US Patent 7060720 Inhibitors of IMPDH enzyme
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
